| 产品详情 |
| Edit |   |
|---|
| Product Name | MDA 19 |
|---|
| Description | A selective agonist of the CB2 receptor, with an EC50 value for CB2 activation (63.4 nM) that is 14-fold lower than that for CB1 activation (EC50 = 867 nM); dose-dependently reduces tactile allodynia in rats and in CB2+/+ mice but not in CB2-/- mice |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor analytical references standards |
|---|
| Gene, Accession, CAS # | CAS: 1048973-47-2 |
|---|
| Catalog # | 10563-50 |
|---|
| Price | |
|---|
| Order / More Info | MDA 19 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|